Evaluation of the Possibilities for Preventing Congenital Toxoplasmosis

American Journal of Perinatology

Volumn 11, Issue 1, 1994, Pages 57-62

  Foulon, W ^a   Naessens, A ^a   Derde, M P ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE;

ARTICLE; CONGENITAL TOXOPLASMOSIS; FEMALE; FETUS; HEALTH EDUCATION; HUMAN; HYGIENE; INCIDENCE; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; PREGNANCY; PRENATAL DIAGNOSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; SCREENING; SECONDARY PREVENTION; SEROCONVERSION; SEROLOGY; TOXOPLASMA GONDII;

EID: 0028118669     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-2007-994537     Document Type: Article

References (13)

1. Thorp JM, Seeds JW, Ilerberi WNP, et al. Prenatal management and congenital toxoplasmosis. N F.ngl J Med 319: 372–373. 1988
2. Foulon W, Nacsscns A, Lauwers S, et al. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol 72: 363–306, 1988
3. McCabe R, Remington JS: Prenatal management and congenital toxoplasmosis. N F.ngl J Med 319: 373–374. 1988
4. Foulon VV, Naessens A, Mahler T, De Waele M, De Catte L, De Meuter F: Prenatal diagnosis of congenital toxoplasmosis. Obstet Gynecol 76: 769–772, 1990
5. Remington JS, Desmonts G: Toxoplasmosis. In Remington JS, Klein JO (cds): Infectious Uncases of the Fetus anti Newborn Infant. Philadelphia: WB Saunders. 1990, pp 89-195
6. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318: 271–275. 1988
7. Couvreur J, Desnionts C, Thulliez P: Prophylaxis of congenital toxoplasmosis: Effects of spiramycin on placental infection. J Antimicrob Chemother 22: 193–200, 1988
8. Ilnhlfeld P, Daffos F, Thulliez P, et al. Fetal toxoplasmosis: Outcome of pregnancy and infant lollow-up after in utero treatment. J Pediatr 115: 765–769, 1989
9. Jackson MU, Hutchison WM, Siim JC: A seroepidemiological survey of toxoplasmosis in Scotland and England. Am Trop Med Parasitol 81: 359–365, 1987
10. Hunter MH, Stagno S, Capps F, et al. Prenatal screening of pregnant women for infections caused by cytomegalovirus, Epslein-Barr virus, herpesvirus, rubella and Toxoplasma gondii. Atn J Obstet Gynecol 145: 269–273, 1983
11. Stray-Pedersen B, Lorentzen-Styr AM: The prevalence of toxoplasma antibodies among 11 736 pregnant women in Norway. Scand J Infect Dis 11: 159–165, 1979
12. Foulon VV, Naessens A, Volckaert M, et al. Congenital toxoplasmosis: A prospective survey in Brussels. Br J Obstet Gynaecol 91: 419–423, 1984
13. Labadie MD, H J. mann JJ: Apport des bilans de santé de l#x0027;enfant pour le dépistage et l#x0027;étude épidémiologique de la toxoplasmose congénitale. Ann Pecliair 31: 823–828, 1984